The CIN subtype accounts for ~50% of GC cases and is characterized by the amplification of receptor tyrosine kinase (RTK) genes, a high frequency of TP53 mutations (in 70% of cases) and CIN, which is indicated by a high frequency of aneuploidy (4,5). The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.